Skip to main content

Advertisement

Log in

Examining the Relationship Between Neurosteroids, Cognition, and Menopause With Neuroimaging Methods

  • Reproductive Psychiatry and Women's Health (CN Epperson and L Hantsoo, Section Editors)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Previous literature has shown inconsistent findings regarding the effects of neurosteroids on the brain in postmenopausal women. The goal of this paper is to examine how and whether advances in neuroimaging have helped elucidate the relationship between the withdrawal of and/or treatment with neurosteroids and cognition at menopause.

Recent Findings

Neuroimaging techniques such as structural and functional MRI have been used in recent studies to examine the relationship between neurosteroids and brain structure and functioning. However, the recent literature shows that different formulations of postmenopausal hormones given at different times, through different routes of administration, and in different combinations with progestins result in a variety of relationships with the brain outcomes.

Summary

We suggest that still further research is needed to understand how the structural changes resulting from estrogen withdrawal or therapy at menopause can influence cognitive functioning. However, imaging studies are time-, resource-, and expertise-intensive. We believe that this information will help uncover the mechanisms and relationships that can aid in the explanation of the individual differences in the effects of menopause on the brain as well as how this menopause-related hormone change influences risk for pathological aging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Berent-Spillson A, Persad CC, Love T, Sowers M, Randolph JF, Zubieta JK, et al. Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab. 2012;97(9):E1686–94. https://doi.org/10.1210/jc.2012-1365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gleason C, Schmitz T, Hess T, Koscik R, Trivedi M, Ries M, et al. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology. 2006;67(11):2039–41. https://doi.org/10.1212/01.wnl.0000247277.81400.43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gibbs RB. Estrogen and nerve growth factor-related systems in brain. Ann N Y Acad Sci. 1994;743(1):165–96. https://doi.org/10.1111/j.1749-6632.1994.tb55792.x.

    Article  CAS  PubMed  Google Scholar 

  4. Gibbs RB. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res. 1996;720(1–2):61–8. https://doi.org/10.1016/0006-8993(96)00106-0.

    Article  CAS  PubMed  Google Scholar 

  5. Lee SJ, McEwen BS. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol. 2001;41:569–91. https://doi.org/10.1146/annurev.pharmtox.41.1.569.

    Article  CAS  PubMed  Google Scholar 

  6. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA. 1992;89(10):4668–72.

    Article  CAS  Google Scholar 

  7. Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology. 2000;149(2):129–39. https://doi.org/10.1007/s002139900324.

    Article  CAS  PubMed  Google Scholar 

  8. Duff SJ, Hampson E. A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Horm Behav. 2000;38(4):262–76. https://doi.org/10.1006/hbeh.2000.1625.

    Article  CAS  PubMed  Google Scholar 

  9. Binder EF, Schechtman KB, Birge SJ, Williams DB, Kohrt WM. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas. 2001;38(2):137–46.

    Article  CAS  Google Scholar 

  10. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging. 2006;27(1):141–9. https://doi.org/10.1016/j.neurobiolaging.2004.12.012.

    Article  CAS  PubMed  Google Scholar 

  11. Halbreich U, Lumley LA, Palter S, Manning C, Gengo F, Joe SH. Possible acceleration of age effects on cognition following menopause. J Psychiatr Res. 1995;29(3):153–63.

    Article  CAS  Google Scholar 

  12. McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (Bethesda, Md : 1985). 2001;91(6):2785–801. https://doi.org/10.1152/jappl.2001.91.6.2785.

    Article  CAS  Google Scholar 

  13. Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas. 2006;53(4):447–53. https://doi.org/10.1016/j.maturitas.2005.07.009.

    Article  PubMed  Google Scholar 

  14. Meyer PM, Powell LH, Wilson RS, Everson-Rose SA, Kravitz HM, Luborsky JL, et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology. 2003;61(6):801–6.

    Article  CAS  Google Scholar 

  15. Greendale GA, Huang M, Wight RG, Seeman T, Luetters C, Avis NE et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. vol 212009. p. 1850–7.

    Article  CAS  Google Scholar 

  16. Luetters C, Huang MH, Seeman T, Buckwalter G, Meyer PM, Avis NE, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women’s health across the nation (SWAN). J Women’s Health (Larchmt). 2007;16(3):331–44.

    Article  Google Scholar 

  17. Maki PM. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience. 2006;138:1027–30.

    Article  CAS  Google Scholar 

  18. Sherwin BB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol. 2007;19(2):77–81.

    Article  CAS  Google Scholar 

  19. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet (London, England). 1996;348(9025):429–32. https://doi.org/10.1016/s0140-6736(96)03356-9.

    Article  CAS  Google Scholar 

  20. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48(6):1517–21.

    Article  CAS  Google Scholar 

  21. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288(17):2123–9.

    Article  CAS  Google Scholar 

  22. Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology. 2012;79(18):1846–52. https://doi.org/10.1212/WNL.0b013e318271f823.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry. 2003;160(8):1522–4. https://doi.org/10.1176/appi.ajp.160.8.1522.

    Article  PubMed  Google Scholar 

  24. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging. 2000;21(2):373–83.

    Article  CAS  Google Scholar 

  25. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause (New York, NY). 2006;13(3):411–22. https://doi.org/10.1097/01.gme.0000189618.48774.7b.

    Article  Google Scholar 

  26. • Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017;1:Cd004143. https://doi.org/10.1002/14651858.CD004143.pub5. This article is a recent Cochrane review of hormone therapy and cogntion

    Article  PubMed  Google Scholar 

  27. Kuh D, Cooper R, Moore A, Richards M, Hardy R. Age at menopause and lifetime cognition: findings from a British birth cohort study. Neurology. 2018;90(19):e1673–e81. https://doi.org/10.1212/wnl.0000000000005486.

    Article  PubMed  PubMed Central  Google Scholar 

  28. • Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, et al. Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis. Neurology. 2016;87(7):699–708. https://doi.org/10.1212/wnl.0000000000002980. This study describes a test of the timing hypothesis for a beneficial effect of estradiol on cogntion after menopause

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ashburner J, Friston KJ. Voxel-based morphometry--the methods. NeuroImage. 2000;11(6 Pt 1):805–21. https://doi.org/10.1006/nimg.2000.0582.

    Article  CAS  PubMed  Google Scholar 

  30. Erickson KI, Colcombe SJ, Raz N, Korol DL, Scalf P, Webb A, et al. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging. 2005;26(8):1205–13. https://doi.org/10.1016/j.neurobiolaging.2004.11.009.

    Article  CAS  PubMed  Google Scholar 

  31. Boccardi M, Ghidoni R, Govoni S, Testa C, Benussi L, Bonetti M, et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a voxel-based morphometry study. Menopause. 2006;13(4):584–91. https://doi.org/10.1097/01.gme.0000196811.88505.10.

    Article  PubMed  Google Scholar 

  32. •• Zhang T, Casanova R, Resnick SM, Manson JE, Baker LD, Padual CB, et al. Effects of hormone therapy on brain volumes changes of postmenopausal women revealed by optimally-discriminative voxel-based morphometry. PloS One. 2016;11(3):e0150834. https://doi.org/10.1371/journal.pone.0150834. This study uses an analysis technique to examine strutural brain differences that is sensitive to group differences to examine the effects of hormone therapy on brain structure

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zhang T, Davatzikos C. Optimally-Discriminative Voxel-Based Morphometry significantly increases the ability to detect group differences in schizophrenia, mild cognitive impairment, and Alzheimer’s disease. NeuroImage. 2013;79:94–110. https://doi.org/10.1016/j.neuroimage.2013.04.063.

    Article  PubMed  PubMed Central  Google Scholar 

  34. •• Kim GW, Park K, Jeong GW. Effects of sex hormones and age on brain volume in post-menopausal women. J Sex Med. 2018;15(5):662–70. https://doi.org/10.1016/j.jsxm.2018.03.006. This study examined the relationship between gray matter change and estradiol level in postmenopausal women

    Article  PubMed  Google Scholar 

  35. •• Albert K, Hiscox J, Boyd B, Dumas J, Taylor W, Newhouse P. Estrogen enhances hippocampal gray-matter volume in young and older postmenopausal women: a prospective dose-response study. Neurobiol Aging. 2017;56:1–6. https://doi.org/10.1016/j.neurobiolaging.2017.03.033. This study examines the effect of estradiol dose on hippocampal volume in postmenopausal women

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. •• Braden BB, Dassel KB, Bimonte-Nelson HA, O’Rourke HP, Connor DJ, Moorhous S, et al. Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memory. Neuropsychology, development, and cognition Section B, Aging, neuropsychology and cognition. 2017;24(3):227–46. https://doi.org/10.1080/13825585.2016.1182962. This study examined hippocampal volume in postmenopausal women and men

    Article  PubMed  Google Scholar 

  37. •• Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Gunter JL, Gleason CE, et al. Effects of hormone therapy on brain structure: a randomized controlled trial. Neurology. 2016;87(9):887–96. https://doi.org/10.1212/wnl.0000000000002970. This study examined the influence of two different formuations of estrogen therapy on brain structure

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. •• Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Lowe VJ, Fields JA, et al. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology. 2018;90(16):e1404–e12. https://doi.org/10.1212/wnl.0000000000005325. This study examined the effects of estrogen therapy on brain structure three years after the discontinuation of the medication

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Berent-Spillson A, Briceno E, Pinsky A, Simmen A, Persad CC, Zubieta JK, et al. Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology. 2015;59:25–36. https://doi.org/10.1016/j.psyneuen.2015.04.020. This study was the first to examine the separate effects of estradiol and progesterone on cognition function after menopause

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. •• Berent-Spillson A, Kelley AS, Persad CC, Love T, Frey KA, Reame NE, et al. Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function. Menopause. 2018; https://doi.org/10.1097/gme.0000000000001157. This is an fMRI study of the effects of hormone therapy on brain funcitoning

  41. •• Girard R, Metereau E, Thomas J, Pugeat M, Qu C, Dreher JC. Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity. Sci Rep. 2017;7:44917. https://doi.org/10.1038/srep44917. This study examined the effects of hormone therapy on cognitive control related brain activation in women who were early post menopause

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Baillie Frizell received support from NIH R25 NS090623. Julie Dumas received support from NIH R01 AG050716.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julie A. Dumas.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Reproductive Psychiatry and Womens Health

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frizell, B., Dumas, J.A. Examining the Relationship Between Neurosteroids, Cognition, and Menopause With Neuroimaging Methods. Curr Psychiatry Rep 20, 96 (2018). https://doi.org/10.1007/s11920-018-0963-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11920-018-0963-2

Keywords

Navigation